Royce & Associates LP Biom X Inc. Transaction History

Royce & Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$0.05 - $10.7 $8,500 - $1.82 Million	-170,000 Reduced 51.73%	158,655 $54,000
Q2 2022 Aug 04, 2022	BUY	$6.4 - $20.2 $51,200 - $161,600	8,000 Added 2.49%	328,655 $240,000
Q1 2022 May 05, 2022	BUY	$12.1 - $20.6 $2.59 Million - $4.41 Million	213,959 Added 200.53%	320,655 $619,000
Q4 2021 Feb 07, 2022	SELL	$14.4 - $30.4 $1.71 Million - $3.62 Million	-119,000 Reduced 52.73%	106,696 $171,000
Q3 2021 Nov 10, 2021	SELL	$30.6 - $58.1 $4.08 Million - $7.74 Million	-133,304 Reduced 37.13%	225,696 $691,000
Q1 2021 May 10, 2021	BUY	$63.1 - $86.4 $22.7 Million - $31 Million	359,000 New	359,000 $2.56 Million

301K

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $19.5M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.